AstraZeneca EBIT 2010-2024 | AZN

AstraZeneca EBIT for the quarter ending June 30, 2024 was $2.746B, a 11.81% increase year-over-year.

  • AstraZeneca 2023 EBIT was 8.193B, a 118.07% increase from 2022.
  • AstraZeneca 2022 EBIT was 3.757B, a 255.78% increase from 2021.
  • AstraZeneca 2021 EBIT was 1.056B, a 79.54% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

AstraZeneca EBIT 2010-2024 | AZN

  • AstraZeneca 2023 EBIT was 8.193B, a 118.07% increase from 2022.
  • AstraZeneca 2022 EBIT was 3.757B, a 255.78% increase from 2021.
  • AstraZeneca 2021 EBIT was 1.056B, a 79.54% decline from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M